SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9 - Solicitation, recommendation statements:
SEC Accession No. 0001193125-20-233615
Filing Date
2020-08-28
Accepted
2020-08-28 06:39:29
Documents
4

Document Format Files

Seq Description Document Type Size
1 SC 14D9 d161225dsc14d9.htm SC 14D9 559059
2 EX-99.(E)(3) d161225dex99e3.htm EX-99.(E)(3) 52254
3 GRAPHIC g161225g07z90.jpg GRAPHIC 29909
4 GRAPHIC g161225g82p37.jpg GRAPHIC 25800
  Complete submission text file 0001193125-20-233615.txt   681114
Mailing Address 220 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 220 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 416-7700
Principia Biopharma Inc. (Filed by) CIK: 0001510487 (see all company filings)

IRS No.: 263487603 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9
SIC: 2834 Pharmaceutical Preparations

Mailing Address 220 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 220 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 416-7700
Principia Biopharma Inc. (Subject) CIK: 0001510487 (see all company filings)

IRS No.: 263487603 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9 | Act: 34 | File No.: 005-90643 | Film No.: 201144828
SIC: 2834 Pharmaceutical Preparations